Association between Chinese visceral adiposity index and heart failure in diabetic patients

Shiwei Kang1, Shuohua Chen2, Zuxu Lin1

  • 1School of Public Health, North China University of Science and Technology, Tangshan, China.

PubMed

Insights

The Chinese visceral adiposity index (CVAI) is linked to a higher risk of heart failure (HF) in diabetic patients. This index is particularly useful for identifying increased HF risk in elderly individuals.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Diabetes mellitus is a significant risk factor for cardiovascular diseases, including heart failure (HF).
  • Visceral adiposity plays a crucial role in the pathogenesis of cardiovascular complications in diabetic individuals.
  • Accurate risk stratification for HF in diabetic populations is essential for effective prevention and management.

Purpose of the Study:

  • To investigate the association between the Chinese visceral adiposity index (CVAI) and the risk of developing heart failure (HF) in patients with diabetes.
  • To compare the predictive capability of CVAI against other established obesity metrics for HF risk.

Main Methods:

  • A prospective cohort study (Kailuan Study) included 12,243 diabetic patients followed from 2006 to 2022.
  • Participants were categorized into quartiles based on their CVAI values.
  • Kaplan-Meier analysis, Cox regression, and ROC analysis were employed to assess the relationship between CVAI and HF incidence and its predictive accuracy.

Main Results:

  • Over a median of 15 years, 861 new HF cases were identified.
  • HF incidence demonstrated a significant increasing trend across higher CVAI quartiles (p < 0.05).
  • Higher CVAI levels were independently associated with increased HF risk, with a notable interaction observed in patients aged 60 years and older.

Conclusions:

  • The Chinese visceral adiposity index (CVAI) is an independent predictor of heart failure risk in diabetic individuals.
  • CVAI demonstrates superior predictive accuracy compared to other obesity indices for HF.
  • CVAI is particularly valuable for risk stratification of visceral fat-related HF, especially in elderly diabetic patients.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
43
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
54
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
38
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
678
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55